A new phage consortium hosts its first public lecture
07 December 2019
This week, Dr. Urmi Bajpai, a phage researcher in New Delhi, India and co-creator of the International Bacteriophage Research Consortium, tells us about a public phage therapy lecture her Consortium held last month to raise awareness of phage therapy and antibiotic resistance in India.
Also in this issue: phages working well against tomato bacteria, collateral effects of phage infection, new investment in the phage biotech company APT, Swiss researchers receive a substantial phage therapy grant, and more!
Further reading: Capsid tail
Author(s): Capsid Tail
Healthy Patients Smart Innovations
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Evotec |
 |
JSS University |
Technology Database
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.
